Evidence map›Paper›PMID 15741317›Full record

ArticleGenes & development2005

Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome.

Heiko Wurdak, Lars M Ittner, Karl S Lang, Per Leveen, Ueli Suter, Jan A Fischer, Stefan Karlsson, Walter Born, Lukas Sommer

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular Pathways and Animal Models of Truncus Arteriosus.Advances in experimental medicine and biology · 2024
    Review
  6. Article
  7. Review
  8. Cranium growth, patterning and homeostasis.Development (Cambridge, England) · 2022
    Article
  9. Article
  10. Article
  11. Craniofacial Phenotypes and Genetics of DiGeorge Syndrome.Journal of developmental biology · 2022
    Review
  12. Article
  13. Article
  14. The TBX1/miR-193a-3p/TGF-Oxidative medicine and cellular longevity · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Heiko WurdakInstitute of Cell Biology, Department of Biology, Swiss Federal Institute of Technology, ETH-Hönggerberg, Zurich, CH-8093, Switzerland.
Lars M Ittner
Karl S Lang
Per Leveen
Ueli Suter
Jan A Fischer
Stefan Karlsson
Walter Born
Lukas Sommer
École Polytechnique Fédérale de Lausanne · CHLund University · SEUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Specific inactivation of TGFbeta signaling in neural crest stem cells (NCSCs) results in cardiovascular defects and thymic, parathyroid, and craniofacial anomalies. All these malformations characterize DiGeorge syndrome, the most common microdeletion syndrome in humans. Consistent with a role of TGFbeta in promoting non-neural lineages in NCSCs, mutant neural crest cells migrate into the pharyngeal apparatus but are unable to acquire non-neural cell fates. Moreover, in neural crest cells, TGFbeta signaling is both sufficient and required for phosphorylation of CrkL, a signal adaptor protein implicated in the development of DiGeorge syndrome. Thus, TGFbeta signal modulation in neural crest differentiation might play a crucial role in the etiology of DiGeorge syndrome.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell DifferentiationDiGeorge SyndromeGene Expression Regulation, DevelopmentalHumansMiceMice, KnockoutNeural CrestNuclear ProteinsPhosphorylationSignal TransductionStem CellsTransforming Growth Factor betaAdaptor Proteins, Signal TransducingCRKL proteinNuclear ProteinsTransforming Growth Factor beta

Identifiers

PMID15741317
PMCPMC551573
OpenAlexW2155466172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.